Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, Sage Therapeutics Inc (NASDAQ: SAGE) closed at $13.69 up 0.81% from its previous closing price of $13.58. In other words, the price has increased by $0.81 from its previous closing price. On the day, 1.49 million shares were traded. SAGE stock price reached its highest trading level at $13.91 during the session, while it also had its lowest trading level at $13.38.
Ratios:
For a deeper understanding of Sage Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.22 and its Current Ratio is at 12.22. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on April 17, 2024, Downgraded its rating to Underperform and sets its target price to $14 from $24 previously.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $21.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 09 ’23 when Barrett Elizabeth bought 2,000 shares for $18.64 per share. The transaction valued at 37,279 led to the insider holds 3,000 shares of the business.
Barrett Elizabeth bought 1,000 shares of SAGE for $50,500 on May 09 ’23. The Director now owns 1,000 shares after completing the transaction at $50.50 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SAGE now has a Market Capitalization of 823891584 and an Enterprise Value of 110185008. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.05 while its Price-to-Book (P/B) ratio in mrq is 1.17. Its current Enterprise Value per Revenue stands at 1.21 whereas that against EBITDA is -0.217.
Stock Price History:
Over the past 52 weeks, SAGE has reached a high of $59.99, while it has fallen to a 52-week low of $10.92. The 50-Day Moving Average of the stock is -27.69%, while the 200-Day Moving Average is calculated to be -38.91%.
Shares Statistics:
For the past three months, SAGE has traded an average of 1.03M shares per day and 1715850 over the past ten days. A total of 60.04M shares are outstanding, with a floating share count of 49.11M. Insiders hold about 18.39% of the company’s shares, while institutions hold 95.05% stake in the company. Shares short for SAGE as of 1713139200 were 9310631 with a Short Ratio of 9.00, compared to 1710460800 on 8399721. Therefore, it implies a Short% of Shares Outstanding of 9310631 and a Short% of Float of 23.369999999999997.
